ERK Inhibitor JSI-1187 in Advanced Solid Tumors

Clinical trial NCT06239623 · UNKNOWN

Trial details

NCT number: NCT06239623
Sponsor: JS InnoPharm, LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor NSCLC Melanoma

Start date: 2022-04-02
Primary completion: 2024-09-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.